Central Nervous System Biomarkers Market: Ongoing Growth with 10.2% CAGR And Boosting Trends Propelling Up to $9 Billion by 2029

"
Emerging Market Size and Growth Projections of the Global Central Nervous System Biomarkers

• The central nervous system biomarkers market size has experienced a boost in recent years, reaching $5.58 billion in 2024 and predicted to attain $6.15 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%.
• This growth is propelled by increasing concerns about neurological disorders, rising prevalence of central nervous system illnesses, advanced health infrastructure, and aging population.
• The market size is slated to see further strong growth, reaching $9 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%.
• Future growth can be attributed to increasing prevalence of neurological disorders, growing demand for personalized medicine, rising geriatric population, and a focus on early diagnosis with non-invasive diagnostic tools.

What Is Driving The Growth In The Central Nervous System Biomarkers Market?

The rise in neurological illnesses is pushing forward the growth of the central nervous system biomarker market. Neurological illnesses, also known as neurological disorders, are broad and can affect the brain, spinal cord, and nerves throughout the body, with causes ranging from genetic factors to traumatic injuries. CNS biomarkers aid clinical diagnosis, determine illness risk, and track treatment response, playing a significant role in understanding these diseases. In 2023, the Centers for Disease Control and Prevention reported that Alzheimer's disease affected an estimated 6.7 million Americans aged 65 and older, a number expected to triple by 2060. This rise in neurological illnesses is driving the growth of the central nervous system biomarker market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12632&type=smp

Who Are the Key Players Driving Central Nervous System Biomarkers Market Growth?

Key players in the market include:

• F. Hoffmann-La Roche AG
• Novartis AG
• Siemens Healthineers
• Thermo Fisher Scientific Inc
• Abbott Laboratories
• Merck KGaA
• Eurofins Scientific
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.

What Are The Key Trends In The Central Nervous System Biomarkers Market?

• New technological advancements
• Strategic collaborations between biotechnology companies, pharmaceutical companies, and other stakeholders
• Growth in research on cerebrospinal fluid (csf) and blood-based biomarkers
• Utilization of AI and machine learning algorithms

What Are The Segments Of The Global Central Nervous System Biomarkers Market?

• By Type: Safety Biomarker, Efficacy Biomarker, Validation Biomarker, Other Types
• By Disease: Multiple Sclerosis, Alzheimer's Disease, Parkinson's Disease, Traumatic Brain Injury, Other Diseases
• By Application: Drug Discovery And Development, Personalized Medicines, Disease Risk Assessment, Diagnostics, Other Applications
• By End-Users: Diagnostic Labs, Clinics, Hospitals, Research Centers, Other End-Users

Which Region Leads The Central Nervous System Biomarkers Market?

North America was the largest region in the central nervous system biomarkers market in 2024. However, the fastest-growing region in the forecast period is expected to be Asia-Pacific. The report covers the central nervous system biomarkers market in various regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

What Is Covered In The Central Nervous System Biomarkers Market Global Market Report?

- Market Size Analysis: Analyze the Central Nervous System Biomarkers Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Central Nervous System Biomarkers Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Central Nervous System Biomarkers Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Central Nervous System Biomarkers Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12632&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

With a collection of over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has earned a reputation for delivering comprehensive, data-rich research and insights. We are armed with 1,500,000 datasets, deep secondary research, and unique insights from industry leaders, enabling you to obtain the information you need to stay ahead.

Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.